The potential of Geraniol (cas 106-24-1) to reduce cytotoxic and genotoxic effects of MNNG in plant and human lymphocyte test-systems
-
Add time:08/19/2019 Source:sciencedirect.com
Geraniol (cas 106-24-1) is a common component of essential oils of various plant species and is widely used in cosmetics, perfumery and household products. In the present study, we investigated the cytotoxic, genotoxic and antioxidant activities of different concentrations of the monoterpenoid geraniol and its anti-cytotoxic and anti-genotoxic potential against the genotoxin N-methyl-N′-nitro-N-nitrosoguanidine (MNNG) in higher plant and human lymphocyte test-systems frequently used in genotoxicity studies. The cytogenetic analysis did not show any inhibition of cell viability for geraniol at concentrations 10–100 μg/ml in barley cells. Only low cytotoxicity was observed in human lymphocytes depending on the concentration. No high clastogenicity for human lymphocytes and low enhancement of the frequencies both of chromosome aberrations and micronuclei were detected in barley. Geraniol showed a good radical-scavenging capacity similar to that of butylated hydroxytoluene (BHT), ascorbic acid and α- tocopherol. Geraniol applied at low nontoxic concentrations possessed a clearly expressed genoprotective potential and could inhibit the cytotoxic/genotoxic effects of MNNG reducing both the frequency of chromosome aberrations and micronuclei induced by the genotoxin. The anti-cytotoxic/anti-genotoxic effects were independent of the experimental schemes of treatment and the test-systems. The obtained results will be useful for further investigations concerning the pharmaceutical and medical application of the monoterpenoid geraniol.
We also recommend Trading Suppliers and Manufacturers of Geraniol (cas 106-24-1). Pls Click Website Link as below: cas 106-24-1 suppliers
Prev:Protective activity of Geraniol (cas 106-24-1) against acetic acid and Helicobacter pylori- induced gastric ulcers in rats
Next:Regular articleAn enzyme-coupled assay enables rapid protein engineering for Geraniol (cas 106-24-1) production in yeast) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Transcriptome analysis and targeted metabolic profiling for pathway elucidation and identification of a Geraniol (cas 106-24-1) synthase involved in iridoid biosynthesis from Gardenia jasminoides08/27/2019
- Effect of Geraniol (cas 106-24-1) on performance, emission and combustion characteristics of CI engine fuelled with gutter oil obtained from different sources08/26/2019
- Protective effect of Geraniol (cas 106-24-1) on the transgenic Drosophila model of Parkinson’s disease08/25/2019
- Original articleGeraniol (cas 106-24-1) alleviates diabetic cardiac complications: Effect on cardiac ischemia and oxidative stress08/24/2019
- In vitro and in vivo biofilm inhibitory efficacy of Geraniol (cas 106-24-1)-cefotaxime combination against Staphylococcus spp.08/23/2019
- Thymoquinone and Geraniol (cas 106-24-1) alleviate cisplatin-induced neurotoxicity in rats through downregulating the p38 MAPK/STAT-1 pathway and oxidative stress08/22/2019
- Manipulation of GES and ERG20 for Geraniol (cas 106-24-1) overproduction in Saccharomyces cerevisiae08/21/2019
- Regular articleAn enzyme-coupled assay enables rapid protein engineering for Geraniol (cas 106-24-1) production in yeast08/20/2019
- Protective activity of Geraniol (cas 106-24-1) against acetic acid and Helicobacter pylori- induced gastric ulcers in rats08/18/2019